Historial del iniciado Otro Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Explore the full record of transactions filed by David Redfern. Officer active across 1 company, notably GSK plc. Aggregated, 117 disclosures have been logged. History available since 9 August 2023. The latest transaction was disclosed on 11 August 2026 (Purchase). Regulator: RNS (LSE). The full history is free.
Companies and markets linked to David Redfern Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones 117 en total
● President, Corporate Development · Directivos · 11 ago 2026 · GSK plc 14 títulos @ 19,3493 GBP ISIN ISIN GB00BN7SWP63RNS:9721245-3 ● President, Corporate Development · Directivos · 11 ago 2026 · GSK plc 14 títulos @ 19,3493 GBP 0.0000% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63FCA-NSM:802aebe3-75c1-4ba5-8333-3c8ccb6de1b0-3 ● President Corporate Development · Directivos · 13 jul 2026 · GSK plc 6 títulos @ 19,755 GBP 0.0000% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:9668630-13 ● President Corporate Development · Directivos · 9 jul 2026 · GSK plc 5803,725 títulos @ 19,6297 GBP 0.015% mcap 0.6% de su flujo ISIN ISIN GB00BN7SWP63RNS:9668630-6 ● President, Corporate Development · Directivos · 10 jul 2026 · GSK plc 784 títulos @ 19,595 GBP 0.0020% mcap 0.1% de su flujo ISIN ISIN GB00BN7SWP63RNS:9668630-19 ● President Corporate Development · Directivos · 13 jul 2026 · GSK plc 18 títulos @ 19,755 GBP 0.0000% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:9668630-24 ● President Corporate Development · Directivos · 9 jul 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:0920c70b-f075-4c99-aba0-46720a29730a-6 ● President Corporate Development · Directivos · 9 jul 2026 · GSK plc 70 títulos @ 19,629 GBP 0.0002% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:9666294-12 ● President, Corporate Development · Directivos · 9 jul 2026 · GSK plc 12 títulos @ 19,6292 GBP 0.0000% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:9666294-3 ● President, Corporate Development · Directivos · 9 jul 2026 · GSK plc 12 títulos @ 19,6292 GBP 0.0000% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-3 ● President Corporate Development · Directivos · 9 jul 2026 · GSK plc 70 títulos @ 19,629 GBP 0.0002% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-12 ● President, Corporate Development · Directivos · 9 jun 2026 · GSK plc 14 títulos @ 18,8393 GBP 0.0000% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:9614374-3 ● President, Corporate Development · Directivos · 9 jun 2026 · GSK plc 14 títulos @ 18,8393 GBP 0.0000% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:03338973-0058-4811-9fe5-7b22157346a2-3 ● President, Corporate Development · Directivos · 12 may 2026 · GSK plc 14 títulos @ 18,778 GBP 0.0000% mcap 100.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:9569357-3 ● President, Corporate Development · Directivos · 12 may 2026 · GSK plc 14 títulos @ 18,6557 GBP 0.0000% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:eaad27f1-a91f-4bc4-815a-149202956de0-3 ● President, Corporate Development · Directivos · 14 abr 2026 · GSK plc 745 títulos @ 21,67 GBP 0.0000% mcap 0.1% de su flujo ISIN ISIN GB00BN7SWP63RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-5 ● President, Corporate Development · Directivos · 13 abr 2026 · GSK plc 10 títulos @ 21,709 GBP 0.0000% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:bae2311e-28b0-4835-a894-0209eedccba9-3 ● President Corporate Development · Directivos · 10 abr 2026 · GSK plc 6 títulos @ 21,6967 GBP 0.0000% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-2 ● President Corporate Development · Directivos · 10 abr 2026 · GSK plc 17 títulos @ 21,6965 GBP 0.0000% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-0 ● President Corporate Development · Directivos · 9 abr 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-10 ● President Corporate Development · Directivos · 9 abr 2026 · GSK plc 67 títulos @ 21,3387 GBP 0.0000% mcap 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-4 ● President, Corporate Development · Directivos · 10 mar 2026 · GSK plc 12 títulos @ 20,7167 GBP 0.0% de su flujo ISIN ISIN GB00BN7SWP63RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-3 ● President, Corporate Development · Directivos · 13 feb 2026 · GSK plc 80.511 títulos @ 21,6002 GBP 9.2% de su flujo ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-17 ● President, Corporate Development · Directivos · 13 feb 2026 · GSK plc 171.300 títulos 0
ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-16 ● President, Corporate Development · Directivos · 12 feb 2026 · GSK plc 143.579 títulos @ 21,50 GBP 16.4% de su flujo ISIN ISIN GB00BN7SWP63RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-9 25 de 117 declaraciones
Ver más (92 restantes) About David Redfern David Redfern is President, Corporate Development at GSK plc (XLON). He has 105 filings in total, and across the sampled recent filings from 2023-08-10 to 2026-06-12, purchases amount to EUR 40049 and sales to EUR 9182238, with Purchase as the modal transaction nature.